The Chemours Co (The Chemours Co) Total Liabilities : $7,512 Mil (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is The Chemours Co Total Liabilities?

The Chemours Co's Total Liabilities for the quarter that ended in Dec. 2023 was $7,512 Mil.

The Chemours Co's quarterly Total Liabilities increased from Jun. 2023 ($6,850.00 Mil) to Sep. 2023 ($7,191.00 Mil) and increased from Sep. 2023 ($7,191.00 Mil) to Dec. 2023 ($7,512.00 Mil).

The Chemours Co's annual Total Liabilities increased from Dec. 2021 ($6,468.00 Mil) to Dec. 2022 ($6,533.00 Mil) and increased from Dec. 2022 ($6,533.00 Mil) to Dec. 2023 ($7,512.00 Mil).

The Chemours Co Total Liabilities Historical Data

The historical data trend for The Chemours Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Chemours Co Total Liabilities Chart

The Chemours Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

6,563.00

6,267.00

6,468.00

6,533.00

7,512.00

The Chemours Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Liabilities	Get a 7-Day Free Trial															6,533.00	6,396.00	6,850.00	7,191.00	7,512.00

The Chemours Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

The Chemours Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	2486	+	(4193	+	714
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	44	+	75)
	=	7,512

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	8251	-	739
	=	7,512

The Chemours Co's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	2486	+	(4193	+	714
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	44	+	75)
	=	7,512

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	8251	-	739
	=	7,512

The Chemours Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of The Chemours Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

The Chemours Co (The Chemours Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » The Chemours Co (NYSE:CC) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

CC:Mexico 2CU:Germany 2CU:Germany

Address

1007 Market Street, Wilmington, DE, USA, 19801

Website

https://www.chemours.com

The Chemours Co is a global provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, etc. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, it derives a majority of its revenue from North America.

Executives

Ron Christopher Charles	officer: Senior Vice President, People	C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Sandra Phillips Rogers	director	1000 CRANBERRY WOODS DRIVE, CRANBERRY TOWNSHIP PA 16066
Erin N Kane	director	300 KIMBALL DRIVE, SUITE 101, PARSIPPANY NJ 07054
Joseph T. Martinko	officer: President, Thermal & Specializ	C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Mark Newman	officer: Senior Vice President and CFO	1011 WARRENVILLE ROAD, SUITE 600, LISLE IL 60532
Alvenia Scarborough	officer: SVP Corp Communications & CBO	C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Matthew S Abbott	officer: SVP, Chief Enterprise Transfor	C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Guillaume Pepy	director	C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Sean D Keohane	director	C/O CABOT CORPORATION, TWO SEAPORT LANE, SUITE 1300, BOSTON MA 02210
Calderon Gerardo Familiar	officer: Pres Advanced Performance Mat	C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Alisha Bellezza	officer: President, Thermal Spec Solns	C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Camela Wisel	officer: VP, CAO & Controller	C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Sameer Ralhan	officer: SVP, CFO	C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19899
Jonathan Lock	officer: SVP, Chief Development Officer	C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Susan M. Kelliher	officer: SVP, People and Health Service	ALBEMARLE CORPORATION, 451 FLORIDA STREET, BATON ROUGE LA 70801